We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA rejected a complaint that it underestimates the amount of time it takes drugmakers to develop standard operating procedures (SOPs) for electronic submission of drug establishment registration and drug listing information.